Systematic Review of Use of Patient-Reported Outcomes in Interventional Radiology.

Autor:	Datta S; New-York Presbyterian Weill Cornell Medical Center, New York, New York., Cramer P; New-York Presbyterian Weill Cornell Medical Center, New York, New York., Sung J; New-York Presbyterian Weill Cornell Medical Center, New York, New York., Wright D; Weill Cornell Medicine, New York, New York., Charalel R; Weill Cornell Medicine, New York, New York; ACR Appropriateness Criteria Interventional Radiology Expert Panel 2 Member. Electronic address: rac9069@med.cornell.edu.
Jazyk:	angličtina
Zdroj:	Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2023 Aug; Vol. 20 (8), pp. 752-757. Date of Electronic Publication: 2023 Jun 29.
DOI:	10.1016/j.jacr.2023.05.009
Abstrakt:	Introduction: A patient-reported outcome (PRO) is any outcome reported directly by the patient, in contradistinction to a clinician-reported outcomes, which have dominated clinical research. This systematic review evaluates the ways in which PROs have been used in the interventional radiology literature. Methods: Systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was designed and conducted by a medical librarian. Studies were screened for inclusion by two independent members, with a third member as a conflict resolver. The data were extracted from each study in a consistent and structured manner. Results: In all, 354 studies met criteria for full-text analysis; 218 of 354 (62%) used a prospective design and most frequently provided level III (249 of 354, 70%) or level I (68 of 354, 19%) evidence. The manner in which PROs were obtained was reported in 125 of 354 (35%) of studies. Questionnaire response rate was documented in 51 of 354 (14%) studies, and questionnaire completion rate was documented in 49 of 354 (14%) studies. Of 354 studies, 281 (79%) studies used at least one independently validated questionnaire. The disease domains most commonly assessed via PRO were women's health (62 of 354, 18%) and men's health (60 of 354, 17%). Discussion: Wider development, validation, and systematic use of PROs in IR would enable more informed patient-centered decision making. A greater focus on PROs in clinical trials would elucidate expected outcomes from the patient's perspective, simplifying comparisons with therapeutic alternatives. To produce more convincing evidence, trials must apply validated PROs rigorously and report possible confounding factors consistently. (Copyright © 2023. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu